US 8003619
Method of stimulating an immune response and inhibiting expression of a gene using an oligonucleotide
granted A61KA61K2039/53A61K39/00
Quick answer
US patent 8003619 (Method of stimulating an immune response and inhibiting expression of a gene using an oligonucleotide) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/53, A61K39/00, A61K39/39, A61P